Filtration Impacts Active Molecule Concentrations in Autologous Serum Eye Drops for Severe Dry Eye

Dry eye disease (DED) is a prevalent condition, accounting for nearly 25% of ophthalmology consultations. Conventional treatments often fall short, leading to persistent symptoms and impaired quality of life. Autologous serum eye drops (ASED) have emerged as a promising therapeutic option for severe DED due to their rich composition of growth factors, vitamins, and immunoglobulins, which support ocular surface healing and reduce inflammation. However, standardization of ASED preparation, particularly regarding filtration steps, remains a critical gap in clinical practice, potentially affecting therapeutic efficacy and patient outcomes.

This study aimed to standardize the preparation of autologous serum eye drops in France by analyzing the impact of filtration. Researchers focused on describing the absolute and relative differences in the concentrations of active molecules in the autologous serum of patients suffering from severe dry eye disease. The methodology involved comparing serum samples before and after filtration to quantify changes in molecular composition. Specific details regarding the number of patients, exact filtration methods, or the panel of "active molecules" analyzed were not provided in the abstract.

The abstract explicitly states the objective to describe the absolute and relative differences in active molecule concentrations before and after filtration of autologous serum from patients with severe dry eye disease. However, it does not present any specific findings, numerical data, statistical results, or identified molecules that were affected by the filtration process. Therefore, no quantitative results, p-values, or fold-changes can be reported from this abstract. The study's aim is to provide foundational data for standardizing ASED preparation, but the results detailing the impact of filtration on specific active molecules are not included in this abstract.